Addex Therapeutics Ltd (ADXN)

0.192
-0.005(-2.34%)
  • Volume:
    278,916
  • Bid/Ask:
    0.181/0.199
  • Day's Range:
    0.180 - 0.200
  • Type:Equity
  • Market:Switzerland
  • ISIN:CH0029850754
  • S/N:2985075

ADXN Overview

Prev. Close
0.197
Day's Range
0.18-0.2
Revenue
4.15M
Open
0.192
52 wk Range
0.18-1.63
EPS
-0.52
Volume
278,916
Market Cap
6.86M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
67,993
P/E Ratio
-
Beta
1.72
1-Year Change
-87.61%
Shares Outstanding
37,887,149
Next Earnings Date
31 Jul 2022
What is your sentiment on Addex Therapeutics Ltd?
or
Market is currently closed. Voting is open during market hours.

Addex Therapeutics Ltd Company Profile

Addex Therapeutics Ltd Company Profile

Employees
27

Addex Therapeutics Ltd is a Switzerland-based clinical-stage pharmaceutical company. The Company focuses on development and commercialization of orally available small molecule drugs known as allosteric modulators for neurological disorders. The Company’s clinical programs pipeline include dipraglurant (mGlu5 NAM), which is Phase 2a placebo-controlled clinical trial for Parkinson's disease levodopa-induced dyskinesia (PD-LID), and is being prepared to enter registration trials for PD-LID, and ADX71149 (mGlu2 positive allosteric modulator or PAM), which is being developed in collaboration by its partner Janssen Pharmaceuticals, Inc to treat schizophrenia and anxious depression. It also is advancing several preclinical programs, including GABABPAM for pain, overactive bladder and other disorders, mGlu7 NAM for post-traumatic stress disorder, mGlu2 NAM for mild neurocognitive disorders, mGlu4 PAM for Parkinson’s disease and mGlu3 PAM for neurodegenerative disorders.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellStrong SellStrong Sell
Technical IndicatorsBuyBuyStrong SellStrong SellStrong Sell
SummaryBuyNeutralStrong SellStrong SellStrong Sell